CD44 and posterior cortical atrophy: The other surprising and remarkable finding of the present study is that etoposide and taxanes, the two chemotherapy drugs commonly used in the clinical treatment of advanced PCa and some other cancers, preferentially deplete the CD44+ Du145 tumor cell population that is known to be enriched in tumor-initiating cells [38], [39].